LAVA Therapeutics NV (LAVA Therapeutics NV) Accounts Receivable : $1.46 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. LAVA Therapeutics NV's accounts receivables for the quarter that ended in Dec. 2023 was $1.46 Mil.

Accounts receivable can be measured by Days Sales Outstanding. LAVA Therapeutics NV's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 377.15.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. LAVA Therapeutics NV's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $1.75.

LAVA Therapeutics NV Accounts Receivable Historical Data

The historical data trend for LAVA Therapeutics NV's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Accounts Receivable Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

0.07

1.14

0.36

3.25

1.46

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Receivable	Get a 7-Day Free Trial												3.25	2.02	3.99	1.08	1.46

LAVA Therapeutics NV Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

LAVA Therapeutics NV Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

LAVA Therapeutics NV's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.459	/	0.353	*	91
=	377.15

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), LAVA Therapeutics NV's accounts receivable are only considered to be worth 75% of book value:

LAVA Therapeutics NV's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(95.571	+	0.75 * 1.459	+	0.5 * 0	-	50.532
-	0	-	0)	/	26.2891
=	1.75

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

LAVA Therapeutics NV Accounts Receivable Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.